GEOFFREY VAN DEN BRANDE: Open Payments
NPI 1154689545 · BURLINGAME, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 6 payments from 6 companies in 2025. Trend: 2023 $735 · 2024 $570 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Biogen, Inc. | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $118 |
| Corcept Therapeutics | 1 | $103 |
| ARGENX US, INC. | 1 | $90 |
| PFIZER INC. | 1 | $90 |
Products named: SPINRAZA, Vascepa, Korlym, VYVGART, HYMPAVZI.
Industry payments across CA — which companies pay providers there.
